PMID- 26421847 OWN - NLM STAT- MEDLINE DCOM- 20160419 LR - 20220408 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 10 IP - 9 DP - 2015 TI - High-Resolution Analyses of Human Leukocyte Antigens Allele and Haplotype Frequencies Based on 169,995 Volunteers from the China Bone Marrow Donor Registry Program. PG - e0139485 LID - 10.1371/journal.pone.0139485 [doi] LID - e0139485 AB - Allogeneic hematopoietic stem cell transplantation is a widely used and effective therapy for hematopoietic malignant diseases and numerous other disorders. High-resolution human leukocyte antigen (HLA) haplotype frequency distributions not only facilitate individual donor searches but also determine the probability with which a particular patient can find HLA-matched donors in a registry. The frequencies of the HLA-A, -B, -C, -DRB1, and -DQB1 alleles and haplotypes were estimated among 169,995 Chinese volunteers using the sequencing-based typing (SBT) method. Totals of 191 HLA-A, 244 HLA-B, 146 HLA-C, 143 HLA-DRB1 and 47 HLA-DQB1 alleles were observed, which accounted for 6.98%, 7.06%, 6.46%, 9.11% and 7.91%, respectively, of the alleles in each locus in the world (IMGT 3.16 Release, Apr. 2014). Among the 100 most common haplotypes from the 169,995 individuals, nine distinct haplotypes displayed significant regionally specific distributions. Among these, three were predominant in the South China region (i.e., the 20th, 31st, and 81sthaplotypes), another three were predominant in the Southwest China region (i.e., the 68th, 79th, and 95th haplotypes), one was predominant in the South and Southwest China regions (the 18th haplotype), one was relatively common in the Northeast and North China regions (the 94th haplotype), and one was common in the Northeast, North and Northwest China (the 40th haplotype). In conclusion, this is the first to analyze high-resolution HLA diversities across the entire country of China, based on a detailed and complete data set that covered 31 provinces, autonomous regions, and municipalities. Specifically, we also evaluated the HLA matching probabilities within and between geographic regions and analyzed the regional differences in the HLA diversities in China. We believe that the data presented in this study might be useful for unrelated HLA-matched donor searches, donor registry planning, population genetic studies, and anthropogenesis studies. FAU - Zhou, Xiao-Yang AU - Zhou XY AD - The Key Laboratory of Geriatrics, Beijing hospital & Beijing Institute of Geriatrics, Ministry of Health, Beijing, China; Quality control laboratory, China Bone Marrow Program, Beijing, China. FAU - Zhu, Fa-Ming AU - Zhu FM AD - HLA Laboratory, Zhejiang Blood Center, Hangzhou, Zhejiang, China. FAU - Li, Jian-Ping AU - Li JP AD - HLA Laboratory, Liaoning Blood Center, Shenyang, Liaoning, China. FAU - Mao, Wei AU - Mao W AD - HLA Laboratory, Chongqing Blood Center, Chongqing, China. FAU - Zhang, De-Mei AU - Zhang DM AD - HLA Laboratory, Taiyuan Red Cross Blood Center, Taiyuan, Shanxi, China. FAU - Liu, Meng-Li AU - Liu ML AD - HLA Laboratory, Shaanxi Blood Center, Xi'an, Shaanxi, China. FAU - Hei, Ai-Lian AU - Hei AL AD - The Key Laboratory of Geriatrics, Beijing hospital & Beijing Institute of Geriatrics, Ministry of Health, Beijing, China; Quality control laboratory, China Bone Marrow Program, Beijing, China. FAU - Dai, Da-Peng AU - Dai DP AD - The Key Laboratory of Geriatrics, Beijing hospital & Beijing Institute of Geriatrics, Ministry of Health, Beijing, China; Quality control laboratory, China Bone Marrow Program, Beijing, China. FAU - Jiang, Ping AU - Jiang P AD - The Key Laboratory of Geriatrics, Beijing hospital & Beijing Institute of Geriatrics, Ministry of Health, Beijing, China; Quality control laboratory, China Bone Marrow Program, Beijing, China. FAU - Shan, Xiao-Yan AU - Shan XY AD - HLA Laboratory, Beijing Red Cross Blood Center, Beijing, China. FAU - Zhang, Bo-Wei AU - Zhang BW AD - HLA Laboratory, Henan Blood Center, Zhengzhou, Henan, China. FAU - Zhu, Chuan-Fu AU - Zhu CF AD - HLA Laboratory, Shandong Blood Center, Jinan, Shandong. FAU - Shen, Jie AU - Shen J AD - HLA Laboratory, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. FAU - Deng, Zhi-Hui AU - Deng ZH AD - The Key Laboratory of Histocompatibility and Immunogenetics, Shenzhen Blood Center, Shenzhen, Guangdong, China. FAU - Wang, Zheng-Lei AU - Wang ZL AD - HLA Laboratory, Hebei Blood Center, Shijiazhuang, Hebei, China. FAU - Yu, Wei-Jian AU - Yu WJ AD - HLA Laboratory, Dalian Red Cross Blood Center, Dalian, Liaoning, China. FAU - Chen, Qiang AU - Chen Q AD - HLA Laboratory, Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu, Sichuan, China. FAU - Qiao, Yan-Hui AU - Qiao YH AD - HLA Laboratory, Xinjiang Blood Center, Urumchi, Xinjiang, China. FAU - Zhu, Xiang-Ming AU - Zhu XM AD - HLA Laboratory, Kunming Blood Center, Kunming, Yunnan, China. FAU - Lv, Rong AU - Lv R AD - HLA Laboratory, Hefei Red Cross Blood Center, Hefei, Anhui, China. FAU - Li, Guo-Ying AU - Li GY AD - HLA Laboratory, Gansu Red Cross Blood Center, Lanzhou, Gansu, China. FAU - Li, Guo-Liang AU - Li GL AD - HLA Laboratory, Jiangxi Blood Center, Nanchang, Jiangxi, China. FAU - Li, Heng-Cong AU - Li HC AD - HLA Laboratory, Nanning Blood Center, Nanning, Guangxi, China. FAU - Zhang, Xu AU - Zhang X AD - HLA Laboratory, Liaoning Blood Center, Shenyang, Liaoning, China. FAU - Pei, Bin AU - Pei B AD - HLA Laboratory, Xiamen Blood Center, Xiamen, Fujian, China. FAU - Jiao, Li-Xin AU - Jiao LX AD - HLA Laboratory, Changchun Blood Center, Changchun, Jilin, China. FAU - Shen, Gang AU - Shen G AD - HLA Laboratory, Wuhan Blood Center, Wuhan, Hubei, China. FAU - Liu, Ying AU - Liu Y AD - HLA Laboratory, Harbin Red Cross Blood Center, Harbin, Heilongjiang, China. FAU - Feng, Zhi-Hui AU - Feng ZH AD - HLA Laboratory, Qingdao Blood Center, Qingdao, Shandong, China. FAU - Su, Yu-Ping AU - Su YP AD - HLA Laboratory, Yueyang Red Cross Blood Center, Yueyang, Hunan, China. FAU - Xu, Zhao-Xia AU - Xu ZX AD - HLA Laboratory, Changsha Blood Center, Changsha, Hunan, China. FAU - Di, Wen-Ying AU - Di WY AD - HLA Laboratory, Soochow Red Cross Blood Center, Suzhou, Jiangsu, China. FAU - Jiang, Yao-Qin AU - Jiang YQ AD - HLA Laboratory, Shanghai Blood Center, Shanghai, China. FAU - Fu, Hong-Lei AU - Fu HL AD - HLA Laboratory, BFR Transplant Diagnostic Service Center, Beijing China. FAU - Liu, Xiang-Jun AU - Liu XJ AD - HLA Laboratory, BFR Transplant Diagnostic Service Center, Beijing China. FAU - Liu, Xiang AU - Liu X AD - HLA Laboratory, CapitalBio Corporation, Beijing, China. FAU - Zhou, Mei-Zhen AU - Zhou MZ AD - HLA Laboratory, Beijing Genomics Institute, Shenzhen, Guangdong, China. FAU - Du, Dan AU - Du D AD - Department of HLA Technology, China Bone Marrow Program, Beijing, China. FAU - Liu, Qi AU - Liu Q AD - Department of HLA Technology, China Bone Marrow Program, Beijing, China. FAU - Han, Ying AU - Han Y AD - Department of HLA Technology, China Bone Marrow Program, Beijing, China. FAU - Zhang, Zhi-Xin AU - Zhang ZX AD - The Key Laboratory of Geriatrics, Beijing hospital & Beijing Institute of Geriatrics, Ministry of Health, Beijing, China; Quality control laboratory, China Bone Marrow Program, Beijing, China. FAU - Cai, Jian-Ping AU - Cai JP AD - The Key Laboratory of Geriatrics, Beijing hospital & Beijing Institute of Geriatrics, Ministry of Health, Beijing, China; Quality control laboratory, China Bone Marrow Program, Beijing, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20150930 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Histocompatibility Antigens Class I) SB - IM MH - Adolescent MH - Adult MH - Alleles MH - Bone Marrow/*immunology MH - China MH - Female MH - *Gene Frequency MH - Genetic Association Studies MH - Haplotypes MH - Histocompatibility Antigens Class I/*genetics MH - Humans MH - Linkage Disequilibrium MH - Male MH - Middle Aged MH - Registries MH - Volunteers MH - Young Adult PMC - PMC4589403 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2015/10/01 06:00 MHDA- 2016/04/20 06:00 PMCR- 2015/09/30 CRDT- 2015/10/01 06:00 PHST- 2015/02/12 00:00 [received] PHST- 2015/09/13 00:00 [accepted] PHST- 2015/10/01 06:00 [entrez] PHST- 2015/10/01 06:00 [pubmed] PHST- 2016/04/20 06:00 [medline] PHST- 2015/09/30 00:00 [pmc-release] AID - PONE-D-15-06541 [pii] AID - 10.1371/journal.pone.0139485 [doi] PST - epublish SO - PLoS One. 2015 Sep 30;10(9):e0139485. doi: 10.1371/journal.pone.0139485. eCollection 2015.